Literature DB >> 7688726

Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene.

P A Marsden1, H H Heng, S W Scherer, R J Stewart, A V Hall, X M Shi, L C Tsui, K T Schappert.   

Abstract

Endothelial nitric oxide (NO) synthase is a unique NO synthase isoform that is expressed constitutively by vascular endothelium both in vivo and in vitro and is believed essential to local vascular homeostasis. This calcium/calmodulin-dependent isoform is distinct from neuronal NO synthase. Genomic clones encoding the human endothelial NO synthase were isolated and the structural organization of the gene was determined. The gene contains 26 exons spanning approximately 21 kilobases of genomic DNA, encodes a messenger RNA of 4052 nucleotides, and is present as a single copy in the haploid human genome. Characterization of 5'-flanking genomic regions indicates that the endothelial NO synthase promoter is "TATA-less" and exhibits proximal promoter elements consistent with a constitutively expressed gene that is found in endothelial cells, namely Sp1 and GATA motifs. The 5'-flanking region contains putative AP-1, AP-2, NF-1, heavy metal, acute-phase response shear stress, and sterol-regulatory cis-elements. The human endothelial NO synthase gene was assigned to the 7q35-->7q36 region of chromosome 7 by Southern blot hybridization of human-rodent somatic cell hybrid lines and fluorescence in situ hybridization, whereas human neuronal NO synthase localized to the 12q24.2 region of chromosome 12.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688726

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  146 in total

1.  Protracted elevation of neuronal nitric oxide synthase immunoreactivity in axotomised adult pudendal motor neurons.

Authors:  A H Pullen; P Humphreys
Journal:  J Anat       Date:  1999-05       Impact factor: 2.610

Review 2.  Endothelial nitric oxide in humans in health and disease.

Authors:  P Vallance; A Hingorani
Journal:  Int J Exp Pathol       Date:  1999-12       Impact factor: 1.925

3.  Minisequencing on oligonucleotide microarrays: comparison of immobilisation chemistries.

Authors:  K Lindroos; U Liljedahl; M Raitio; A C Syvänen
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

4.  Endothelial venodilator response in carriers of genetic polymorphisms involved in NO synthesis and degradation.

Authors:  Ruth Fricker; Christiane Hesse; Johanna Weiss; Yorki Tayrouz; Michael M Hoffmann; Kristina Unnebrink; Ulrich Mansmann; Walter E Haefeli
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

5.  Physiopathology of splanchnic vasodilation in portal hypertension.

Authors:  María Martell; Mar Coll; Nahia Ezkurdia; Imma Raurell; Joan Genescà
Journal:  World J Hepatol       Date:  2010-06-27

6.  FGF21 inhibitor suppresses the proliferation and migration of human umbilical vein endothelial cells through the eNOS/PI3K/AKT pathway.

Authors:  Yumei Li; Jiangnan Huang; Zhiyuan Jiang; Yang Jiao; Hui Wang
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

7.  Endothelial nitric oxide synthase gene intron 4 a/b VNTR polymorphism in children with APSGN.

Authors:  Hasan Dursun; Aytul Noyan; Selcuk Matyar; Mithat Buyukcelik; Mustafa Soran; Nurcan Cengiz; Gulsah Seydaoglu; Gulen Attila; Aysun K Bayazit; Ali Anarat
Journal:  Pediatr Nephrol       Date:  2006-08-29       Impact factor: 3.714

8.  Endothelial dysfunction in children with obstructive sleep apnea is associated with epigenetic changes in the eNOS gene.

Authors:  Leila Kheirandish-Gozal; Abdelnaby Khalyfa; David Gozal; Rakesh Bhattacharjee; Yang Wang
Journal:  Chest       Date:  2013-04       Impact factor: 9.410

9.  Cyclic strain upregulates nitric oxide synthase in cultured bovine aortic endothelial cells.

Authors:  M A Awolesi; W C Sessa; B E Sumpio
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

Review 10.  Endothelial nitric oxide synthase polymorphisms and hypertension.

Authors:  Aroon D Hingorani
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.